CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 75 target
Drug / intervention
Glutamine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03917095
NCT03917095N/AUnknown
CompareCT.gov

Mesalazine and Compound Glutamin Enema for the Treatment of Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing: A Multicenter, Randomized, Controlled Trail

The Second Hospital of Nanjing Medical University·interventional·Posted Apr 16, 2019·Updated May 15, 2019

In Brief

A clinical study evaluating The Colonic Transendoscopic enteral Tubing., Glutamine, and 1 other intervention for Ulcerative Colitis Chronic Mild and Ulcerative Colitis Chronic Moderate. Targeting 75 participants across 1 site.

Detailed Summary

Colonic Transendoscopic enteral Tubing(TET) is a novel, safe, convenient, and reliable procedure for Fecal Microbiota Transplantation(FMT).This clinical trail aims to evaluate the efficacy and safety of Mesalazine and Compound Glutamine enema in the treatment of Ulcerative Colitis through Colonic TET.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUlcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate
CountriesChina
Collaborators--

Timeline

N/AUnknownOverdue
2020202120222023202420252026
First PostedApr 16, 2019
Enrollment StartMay 15, 2019
Primary CompletionJun 15, 2019
Study CompletionJun 30, 2019
TodayJul 1, 2026
Enrollment to primary: 1 monthPosted 7.2 years ago

Interventions

The Colonic Transendoscopic enteral Tubing.device

The medications were infused into the colon through the Colonic Transendoscopic enteral Tubing(TET).

Glutaminedrug

The medications were infused into the colon

Mesalazinedrug

The medications were infused into the colon